The Maurice R. Hilleman Center for Vaccine Manufacturing is a state-of-the-art facility in northern Durham, North Carolina. Nestled among the trees in Treyburn Corporate Park, the modern, "green" facility is Merck's response to a growing vaccine business. Construction of the site began in 2004, with a vaccine formulation and filling manufacturing facility, warehouse, energy center and office building. Since then an additional vaccine formulation and filling manufacturing facility, a vaccine bulk manufacturing facility and a release laboratory have been completed.
The Hilleman Center manufactures childhood vaccines for measles, mumps, rubella and chickenpox, as well as the adult vaccine for shingles. The 900,000+ square foot facility is a key part of Merck's vaccine strategy to ensure we have the long-term supply capabilities to meet the worldwide public health needs for the vaccines we manufacture. An empowered, team based culture provides our employees with the opportunity to be part of decision making processes that impact their work and instills a level of pride and ownership in what we do every day to save and improve lives.
The facility was built from the ground up with technology, knowing that our success is based on the quality of the data we produce just as much as the quality of the products we bring to the market. Attend this plant tour, which will be followed by an executive roundtable discussion on Manufacturing Innovation and the Digital Journey, and walk away with actionable insights, including:
This automated equipment is capable of calculating the potency of the Varicella virus for 5,000 individual samples every 3 days. Find out how this helps us ensure product quality and meet our goal of providing vaccines to the world market.
Vice President and CIO, Manufacturing IT
Manufacturing Leadership Council Member
Schedule in progress. Please anticipate that this tour will end between 4:00pm - 5:00pm EST to plan your travel accordingly.